XML 31 R23.htm IDEA: XBRL DOCUMENT
v3.19.3

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Stock-Based Compensation Plans During the nine months ended September 30, 2019, we had two stock benefits plans under which restricted stock, stock options and performance awards have been granted or remain outstanding: the Second Amended and Restated 2006 Long-Term Incentive Plan (the “Amended and Restated 2006 Plan”) and the 2017 Omnibus Incentive Plan (the “2017 Plan”). The Amended and Restated 2006 Plan was terminated upon the approval of the 2017 Plan at the annual shareholders meeting on May 17, 2017, however, the termination of the Amended and Restated 2006 Plan does not affect the awards previously issued and outstanding under the Amended and Restated 2006 Plan. All stock-based plans are administered by the Compensation Committee appointed by our Board of Directors (the “Board”). The 2017 Plan provides for grants of options as non-qualified options or incentive stock options, restricted stock and performance awards. The 2017 Plan expires on May 17, 2027. The status of each of the plans at September 30, 2019 is as follows (shares in thousands):
| Shares Reserved |  | Shares Available to Issue |  | Options Outstanding |  | Performance Awards Outstanding (2)
Amended and Restated 2006 Plan | — |  |  | — |  |  | 940 |  |  | — |
2017 Plan | 2,709 |  | (1) | 1,952 |  |  | 136 |  |  | 501 |
Total | 2,709 |  |  | 1,952 |  |  | 1,076 |  |  | 501 |
(1) | Amount includes approximately 1,154,000 shares granted from the Amended and Restated 2006 Plan that were returned to the Company due to cancellations, to pay taxes on restricted stock vestings and to pay option price and taxes on option exercises.
(2) | Performance Awards are reserved at 200% of shares granted which is equal to the maximum payout in shares.
Restricted Stock We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for restricted stock awards of $215,000 and $196,000, for the three months ended September 30, 2018 and 2019, respectively and $681,000 and $624,000 for the nine months ended September 30, 2018 and 2019, respectively. As of September 30, 2019, we had $1.7 million of total unrecognized compensation costs related to unvested restricted stock awards, which are expected to be recognized over a weighted average period of approximately 1.7 years. Stock Options We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for stock options of $238,000 and $160,000, for the three months ended September 30, 2018 and 2019, respectively and $955,000 and $513,000 for the nine months ended September 30, 2018 and 2019, respectively. Performance Awards We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for performance awards of $344,000 and $61,000 for the three months ended September 30, 2018 and 2019, respectively and $964,000 and $138,000 for the nine months ended September 30, 2018 and 2019, respectively. Employee Stock Purchase Plan We recorded stock-based compensation expense, which is included in General, administrative and other expenses, for the ESPP totaling $58,000 for both the three months ended September 30, 2018 and 2019 and $208,000 and $224,000 for the nine months ended September 30, 2018 and 2019, respectively. Director Compensation We recorded stock-based compensation expense, which is included in General, administrative and other expenses, related to annual retainers and common stock awards of $133,000 and $113,000 for the three months ended September 30, 2018 and 2019, respectively and $336,000 and $341,000 for the nine months ended September 30, 2018 and 2019, respectively. Share Repurchase During the nine months ended September 30, 2019, we repurchased 400,000 shares of common stock for a total cost of $7.8 million at an average cost of $19.39 per share pursuant to our share repurchase program. At September 30, 2019, we had approximately $0.6 million available for repurchases under our share repurchase program. Cash Dividends During the nine months ended September 30, 2018 and 2019, our Board declared the following dividends payable on the dates below (in thousands, except per share amounts):
2018 | Per Share |  | Dollar Value
March 1 st | $ | 0.075 |  |  | $ | 1,207 |
June 1 st | $ | 0.075 |  |  | $ | 1,433 |
September 1 st | $ | 0.075 |  |  | $ | 1,436 |
2019 | Per Share |  | Dollar Value
March 1 st | $ | 0.075 |  |  | $ | 1,360 |
June 3 rd | $ | 0.075 |  |  | $ | 1,365 |
September 1 st | $ | 0.075 |  |  | $ | 1,336 |
Accumulated other comprehensive income Our components of accumulated other comprehensive income are as follows (in thousands):
| Accumulated Other Comprehensive Income
Balance at December 31, 2018 | $ | — |
Decrease in net unrealized gains associated with available-for-sale securities of the trusts | (6,560 | )
Reclassification of net unrealized gain activity attributable to the Deferred preneed funeral and cemetery receipts held in trust and Care trusts’ corpus | 6,560 |
Balance at September 30, 2019 | $ | — |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration